Results 41 to 50 of about 28,980 (179)

Medical and neurodevelopmental outcomes at 10 months of age in infants born at 34 weeks plus to mothers with COVID‐19

open access: yes, 2023
Acta Paediatrica, Volume 112, Issue 2, Page 296-297, February 2023.
Antoine Martenot   +4 more
wiley   +1 more source

Evaluation of Arclight Frugal Smartphone Video Otoscopy

open access: yesThe Laryngoscope, EarlyView.
Frugal innovations are essential in low‐resource settings to provide cost‐effective medical solutions without compromising functionality. The Arclight, which functions as both an ophthalmoscope and an otoscope, is an effective, low‐cost tool for (video) ear examinations in low‐resource settings.
Christoph R. Buhr   +7 more
wiley   +1 more source

Reduction of Rescue Treatment With Dupilumab for Chronic Rhinosinusitis With Nasal Polyps in Japan

open access: yesThe Laryngoscope, EarlyView.
This observational study examined the impact of add‐on dupilumab treatment on the use of rescue therapy in Japanese individuals with chronic rhinosinusitis with nasal polyps (CRSwNPs) using data from a large hospital‐based administrative claims database.
Mamoru Yoshikawa   +5 more
wiley   +1 more source

Sinonasal Intervention Reduces the Need for Pressure Equalization Tube Placement in Atopic Adults

open access: yesThe Laryngoscope, EarlyView.
Surgical and medical management of atopic sinonasal diseases decreases the risk of middle ear disease and the subsequent need for pressure equalization tubes. ABSTRACT Objectives To determine the impact of management of upper airway atopic disease on middle ear and eustachian tube function in adults.
Lawrance Lee   +3 more
wiley   +1 more source

Break down the barriers of auto‐inflammation: How to deal with a monogenic auto‐inflammatory disease and immuno‐haematological features in 2022?

open access: yesImmunology, Volume 168, Issue 1, Page 1-17, January 2023., 2023
In the past few years, the spectrum of monogenic systemic auto‐inflammatory diseases has widely expanded beyond the typical recurrent fever. Immuno‐haematological features, as cytopenias, hypogammaglobulinemia, hypereosinophilia, lymphoproliferation and immunodeficiency, have been described in association of several MSAID.
Hélène Vergneault   +2 more
wiley   +1 more source

Screening by high‐throughput sequencing for pathogenic variants in cystic fibrosis: Benefit of introducing personalized therapies

open access: yesJournal of Cellular and Molecular Medicine, Volume 26, Issue 23, Page 5943-5947, December 2022., 2022
Abstract This short report documented cystic fibrosis transmembrane conductance regulator (CFTR) variants in 37 patients with cystic fibrosis (CF) in the Rio Grande do Norte region of Northeast Brazil. The high‐throughput sequencing technology (HTS) genetic testing provided a definitive molecular diagnosis in 31 patients (83.8%).
Ana Cristina Vieira de Melo   +6 more
wiley   +1 more source

Evaluating Adverse Outcomes After Myringotomy or Tube Placement in Head and Neck Cancer

open access: yesOtolaryngology–Head and Neck Surgery, EarlyView.
Abstract Objective Evaluate rates of adverse outcomes among patients with a history of head and neck cancer undergoing myringotomy with or without tube placement for middle ear effusion. Study Design Retrospective chart review. Setting Academic medical center.
Krithika Kuppusamy   +7 more
wiley   +1 more source

Feasibility of Stepwise Technology‐Based Audiometry With Rapid Results (STARR) Protocol in Minnesota Elementary Schools

open access: yesOtolaryngology–Head and Neck Surgery, EarlyView.
Abstract Objective This study aims to understand the utility of a stepwise technology‐based audiometry with rapid results (STARR) school screening protocol. Study Design A prospective cohort study. Setting Six elementary schools in a single school district in Minnesota.
Autefeh Sajjadi   +15 more
wiley   +1 more source

Response to sequential treatment with prednisolone and vigabatrin in infantile spasms

open access: yesJournal of Paediatrics and Child Health, Volume 58, Issue 12, Page 2197-2202, December 2022., 2022
Aim To report response to first treatment in infants with infantile spasms (IS), including incremental benefit of prednisolone 60 mg/day and vigabatrin following prednisolone 40 mg/day failure in infants commenced on the United Kingdom Infantile Spasms Study (UKISS) treatment sequence.
Winston Dzau   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy